Calhoun Kirk K
SEC-identified person · CIK 1203721 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ryerson Holding Corp ryi | Director | filed 2014 - 2026 |
| Nanthealth, Inc. NHIQ | Director | filed 2016 - 2022 |
| PLx Pharma Inc. PLXP | Director | filed 2017 - 2022 |
| Response Genetics INC rgdx | Director | filed 2008 - 2014 |
| New Abraxis, Inc. ABII | Director | filed 2007 - 2010 |
| Replidyne INC RDYN | Director | filed 2006 - 2008 |
| Adams Respiratory Therapeutics, Inc. ARXT | Director | filed 2006 - 2008 |
| Myogen INC MYOG | Director | filed 2006 - 2006 |
| Abraxis Bioscience, Inc. (Abbi) APPX | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.